Effect of Phytosulfokine-α on Agrobacterium-Mediated Transformation in Rice

Phytosulfokine(PSK)is a new peptide plant hormone,which was isolated in the conditioned medium of cultures derived from both monoco-tyledonous and dicotyledonous plants,such as Asparagus officinalis mesophyll[1],rice[2],zinnia[3],and carrot[4].PSK has two types of structure:PSK-αand PSK-β.The former is a sulfated pentapeptide[H-Tyr(SO3H)-Ile-Tyr(SO3H)-Thr-Gln-OH],the latter is a sulfated terapeptide[H-Tyr(SO3H)-Ile-Tyr(SO3H)-Thr-OH].Both are heat-stable,susceptible to pronase…     

Pharmacokinetic and Phase I Evaluation of Carboplatin in Dogs

Thirty dogs with spontaneously occurring malignant neoplasms were treated monthly with carboplatin (CBDCA) given as a 30-minute intravenous infusion in a dose escalation study. Twenty-eight dogs were considered evaluable for toxicity. The maximally tolerated dose of CBDCA was conceptually defined as that dose, determined by logistic regression analyses of toxicity data, resulting in a 50% incidence of moderate toxicity (MOD₅₀) or a 5% incidence of severe toxicity (SEV₅). Each designated maximally tolerated dose was calculated for the first course of treatment only and for the first and second courses of treatment combined to estimate cumulative drug toxicity. The MOD₅₀ and SEV₅ for the first treatment course were 340 and 278 mg/M², respectively. MOD₅₀ and SEV₅ values for the first plus second treatment courses were 327 and 231 mg/M², respectively. The nadir of neutrophil and platelet counts occurred approximately 14 days after treatment. The mean neutrophil and platelet values for all dogs experiencing myelosuppression during the first two treatment courses were 1541/μL and 62,600/μL, respectively. Nonparametric pharmacokinetic analysis of plasma CBDCA values suggested that half-life (T_1/2), area-under-the-curve and total body clearance (CL_b) were not dose dependent. Volume of distribution (VD_ss) significantly increased with dose only between 100 and 150 mg/M², not between 150 and 300 mg/M². Dose-independent serum CBDCA pharmacokinetic disposition indicates that detailed investigation of tissue CBDCA distribution would be warranted and may identify novel dosing strategies that could improve the therapeutic index of CBDCA by minimizing toxicity. (Journal of Veterinary Internal Medicine 1993; 7:235–240. Copyright © 1993 by the American College of Veterinary Internal Medicine.)     

SH系砧木及对应中间砧红富士苹果枝条水分输导阻力研究

为进一步揭示砧木的矮化机理 ,以SH系矮化砧木及相应中间砧红富士苹果为试材 ,在生长季测定砧木枝条及嫁接部位的水分输导阻力。结果表明 ,SH系砧木枝条及嫁接部位的水分输导阻力 ,随砧木矮化程度的升高而增大 ,表明水分输导阻力的增加 ,是导致嫁接树矮化的原因之一。     

钢质管道支座处的腐蚀控制方法

钢质管道与支座接触处及其周围的腐蚀比其它非特殊部位严重,由于其不易发现而被忽略,难以维护和重新防腐,易造成安全隐患.通过分析这种现象的形成原因,提出了三种有效控制支座处管道腐蚀的新型支座结构方案,可从根本上解决钢质管道与支座接触处的腐蚀问题.     

日粮锌、硒水平对肉鸡肠道黏膜屏障结构的影响

为了探讨微量元素锌和硒相互作用对肉鸡肠道黏膜屏障结构的影响，将24只1日龄AA肉鸡随机分3组，分别饲喂添加有高锌高硒(锌1000mg／kg、硒5mg／kg)、低锌低硒(锌34mg／kg、硒0．08mg／kg)或常锌常硒(锌50mg／kg、硒0．15mg／kg)的日粮45d后，观察肠黏膜上皮细胞、上皮内淋巴细胞和盲肠扁桃体的形态结构变化。结果表明：高锌高硒或低锌低硒组肉鸡的肠黏膜结构有明显的损伤，表现为肠黏膜上皮细胞萎缩，绒毛长度下降，上皮内淋巴细胞数量减少；盲肠扁桃体的弥散淋巴组织和淋巴小结中，淋巴细胞数量减少，细胞出现肿胀，有的核消失，结缔组织增生，淋巴小结萎缩。尤其是高锌高硒组的损伤最为严重。而常锌常硒组肉鸡肠黏膜和盲肠扁桃体的形态结构正常。结论：日粮中按锌50mg／kg、硒0．15mg／kg的比例添加，对于维持肠道黏膜的正常屏障结构是合适的。过高或过低的锌和硒对小肠黏膜有毒性作用，破坏其屏障功能；而且高锌和高硒可相互促进以增强其毒性作用。     

哺乳动物体细胞克隆研究进展

哺乳动物体细胞克隆技术是近年来才发展起来的技术，但体细胞克隆绵羊－多利的诞生却引起了世界轰动，充分显示了其重在的科学研究价值和潜在的应用价值。本文对哺乳动物体细胞克隆技术研究现状，理论基础研究，应用等方面作一综述。     

生物素对肉仔鸡脾脏细胞PCNA基因的mRNA表达的影响

采用分子生物学方法研究了生物素对脾脏细胞增殖细胞核抗原（PCNA）基因的mRNA表达的影响。将60只1日龄AA雄性肉仔鸡随机分成3个处理，每个处理20只鸡，基础日粮为小麦-酪蛋白-鱼粉型日粮，在基础日粮中分别添加0．30mg／kg和2．7mg／kg2个水平的生物素，包括对照组共计3种日粮处理，为了刺激PCNA基因表达产物mRNA的表达，在48日龄采用皮下注射方式定量接种禽流感疫苗。结果表明：添加生物素显著提高了脾脏细胞PCNA基因表达产物mRNA的表达量（P〈0．01），其中2．7mg／kg处理组极显著高于对照组和0．3mg／kg处理组（P〈O．01），0．3mg／kg处理组和对照组之间无显著性差异（P〉0．05），由此推断，生物素通过促进脾脏细胞PCNA基因的mRNA表达，进而促进脾脏细胞的增殖。     

棉花枯、黄萎病菌营养亲和性研究进展

介绍了棉花枯、黄萎病菌营养亲和性研究方法和营养体亲和群研究,并着重总结了利用营养亲和群结合DNA多态性技术,研究尖孢镰刀菌(FusariumoxysporumSchlechtend:Fr)专化型、生理小种、亲和群之间的关系,以及棉花黄萎病菌(VerticilliumdahliaeKleb.)亲和群与致病型关系的研究进展。     

Proposed criteria for classification of acute myeloid leukemia in dogs and cats

Blood and bone marrow smears from 49 dogs and cats, believed to have myeloproliferative disorders (MPD), were examined by a panel of 10 clinical pathologists to develop proposals for classification of acute myeloid leukemia (AML) in these species. French-American-British (FAB) group and National Cancer Institute (NCI) workshop definitions and criteria developed for classification of AML in humans were adapted. Major modifications entailed revision of definitions of blast cells as applied to the dog and cat, broadening the scope of leukemia classification, and making provisions for differentiating erythremic myelosis and undifferentiated MPD. A consensus cytomorphologic diagnosis was reached in 39 (79.6%) cases comprising 26 of AML, 10 of myelodysplastic syndrome (MDS), and 3 of acute lymphoblastic leukemia (ALL). Diagnostic concordance for these diseases varied from 60 to 81% (mean 73.3 +/- 7.1%) and interobserver agreement ranged from 51.3 to 84.6% (mean 73.1 +/- 9.3%). Various subtypes of AML identified included Ml, M2, M4, M5a, M5b, and M6. Acute undifferentiated leukemia (AUL) was recognized as a specific entity. M3 was not encountered, but this subclass was retained as a diagnostic possibility. The designations M6Er and MDS-Er were introduced where the suffix "Er" indicated preponderance of erythroid component. Chief hematologic abnormalities included circulating blast cells in 98% of the cases, with 36.7% cases having >30% blast cells, and thrombocytopenia and anemia in approximately 86 to 88% of the cases. Bone marrow examination revealed panmyeloid dysplastic changes, particularly variable numbers of megaloblastoid rubriblasts and rubricytes in all AML subtypes and increased numbers of eosinophils in MDS. Cytochemical patterns of neutrophilic markers were evident in most cases of Ml and M2, while monocytic markers were primarily seen in M5a and M5b cases. It is proposed that well-prepared, Romanowsky-stained blood and bone marrow smears should be examined to determine blast cell types and percentages for cytomorphologic diagnosis of AML. Carefully selected areas of stained films presenting adequate cellular details should be used to count a minimum of 200 cells. In cases with borderline diagnosis, at least 500 cells should be counted. The identity of blast cells should be ascertained using appropriate cytochemical markers of neutrophilic, monocytic, and megakaryocytic differentiation. A blast cell count of > 30% in blood and/or bone marrow indicates AML or AUL, while a count of < 30% blasts in bone marrow suggests MDS, chronic myeloid leukemias, or even a leukemoid reaction. Myeloblasts, monoblasts, and megakaryoblasts comprise the blast cell count. The FAB approach with additional criteria should be used to distinguish AUL and various subtypes of AML (Ml to M7 and M6Er) and to differentiate MDS, MDS-ER, chronic myeloid leukemias, and leukemoid reaction. Bone marrow core biopsy and electron microscopy may be required to confirm the specific diagnosis. Immunophenotyping with lineage specific antibodies is in its infancy in veterinary medicine. Development of this technique is encouraged to establish an undisputed identity of blast cells. Validity of the proposed criteria needs to be substantiated in large prospective and retrospective studies. Similarly, clinical relevance of cytomorphologic, cytochemical, and immunophenotypic characterizations of AML in dogs and cats remains to be determined.